Dr. Patricia LoRusso on Next-Generation Sequencing Benefit in Metastatic Melanoma Treatment
October 16th 2015Patricia M. LoRusso, DO, Professor of Medicine and Associate Director of Innovative Medicine, Yale Cancer Center, discusses taking a personalized medicine approach to treat melanoma patients whose tumors do not have BRAF alterations.
Read More